Detalhe da pesquisa
1.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(8): 1110-1122, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32702309